Literature DB >> 34283191

Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk.

John T Wilkins1,2, Donald M Lloyd-Jones1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34283191     DOI: 10.1001/jama.2021.2244

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial.

Authors:  Omar Dzaye; Alexander C Razavi; Erin D Michos; Martin Bødtker Mortensen; Zeina A Dardari; Khurram Nasir; Albert D Osei; Allison W Peng; Ron Blankstein; John H Page; Michael J Blaha
Journal:  Atherosclerosis       Date:  2022-02-12       Impact factor: 6.847

2.  Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management.

Authors:  Nikhil K Khankari; Jacob M Keaton; Venexia M Walker; Kyung Min Lee; Megan M Shuey; Shoa L Clarke; Kent R Heberer; Donald R Miller; Peter D Reaven; Julie A Lynch; Marijana Vujkovic; Todd L Edwards
Journal:  EBioMedicine       Date:  2022-04-29       Impact factor: 11.205

3.  Lipid-Lowering Efficacy of Kuding Tea in Patients With Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Zhonghui Jiang; Zhuqing Lu; Tianyi Wang; Yilian Wang; Jianfeng Chu; Keji Chen; Zhuye Gao
Journal:  Front Nutr       Date:  2022-04-28

4.  Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United States.

Authors:  Dylan L Steen; Irfan Khan; Katherine Andrade; Alexandra Koumas; Robert P Giugliano
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

Review 5.  HIV: how to manage dyslipidaemia in HIV.

Authors:  Daniel Lee
Journal:  Drugs Context       Date:  2022-03-01

6.  Low-Density Lipoprotein Cholesterol Levels in Coronary Artery Disease Patients: Opportunities for Improvement.

Authors:  Gary J Martin; Meron Teklu; Edwin Mandieka; Joe Feinglass
Journal:  Cardiol Res Pract       Date:  2022-04-27       Impact factor: 1.990

Review 7.  Inflammation and atherosclerosis: signaling pathways and therapeutic intervention.

Authors:  Peng Kong; Zi-Yang Cui; Xiao-Fu Huang; Dan-Dan Zhang; Rui-Juan Guo; Mei Han
Journal:  Signal Transduct Target Ther       Date:  2022-04-22

Review 8.  Lipid Variability and Risk of Cardiovascular Diseases and All-Cause Mortality: A Systematic Review and Meta-Analysis of Cohort Studies.

Authors:  Shuting Li; Leying Hou; Siyu Zhu; Qian Yi; Wen Liu; Yang Zhao; Feitong Wu; Xue Li; An Pan; Peige Song
Journal:  Nutrients       Date:  2022-06-13       Impact factor: 6.706

9.  Knowledge, Attitude, and Practice Toward Cardiovascular Diseases in the Lebanese Population.

Authors:  Marc Machaalani; Battoul Fakhry; Maisoon Zwaideh; Karl Mendelek; Nadine Mahmoud; Talal Hammoud; Mirna N Chahine
Journal:  Glob Heart       Date:  2022-07-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.